Canadian Liver Journal

Scope & Guideline

Advancing Hepatology through Innovative Research.

Introduction

Welcome to your portal for understanding Canadian Liver Journal, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherUNIV TORONTO PRESS INC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCAN LIVER J / Can. Liver J.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA

Aims and Scopes

The Canadian Liver Journal focuses on advancing the field of hepatology through research that encompasses various aspects of liver health, disease management, and the socio-economic factors affecting liver disease in Canada. It aims to disseminate high-quality, evidence-based studies that contribute to the understanding and treatment of liver conditions.
  1. Hepatitis Management and Research:
    The journal emphasizes research on hepatitis viruses, including hepatitis B and C, focusing on epidemiology, treatment efficacy, and elimination strategies.
  2. Liver Transplantation and Eligibility:
    A core area is the study of liver transplantation, including recipient selection, eligibility criteria, and outcomes, reflecting the evolving practices in transplant medicine.
  3. Impact of Lifestyle on Liver Health:
    Research focusing on lifestyle factors affecting liver health, such as alcohol use, diet, and exercise, is prevalent, indicating the journal's commitment to preventive hepatology.
  4. Health Disparities and Access to Care:
    The journal addresses disparities in liver disease management, particularly among Indigenous populations and marginalized communities, highlighting the need for equitable healthcare access.
  5. Innovative Therapies and Treatment Approaches:
    There is a strong focus on novel therapeutic approaches, including direct-acting antivirals for hepatitis C and other emerging treatments for liver diseases.
  6. Public Health and Policy Implications:
    The journal includes studies that examine the public health implications of liver diseases and the effectiveness of health policies aimed at improving liver health outcomes.
Recent publications in the Canadian Liver Journal reflect emerging trends and themes that are gaining traction in the field of hepatology. These trends indicate a progressive focus on innovative research areas and the evolving landscape of liver disease management.
  1. Telehealth and Digital Health Solutions:
    There is an increasing interest in the role of digital health interventions, such as app-based solutions for managing liver disease, reflecting broader trends in healthcare technology.
  2. Intersection of Hepatology and Mental Health:
    Emerging research explores the psychological aspects of liver diseases, including mental health outcomes for patients with chronic liver conditions, highlighting the need for holistic care.
  3. Inclusive Research Practices:
    A growing emphasis on inclusivity in research methodologies, particularly involving Indigenous populations and other marginalized groups, is evident, aiming to address health disparities.
  4. COVID-19 Impact on Liver Health:
    The journal has seen an uptick in studies examining the intersection of liver disease management and the COVID-19 pandemic, focusing on its implications for treatment and healthcare access.
  5. Integration of Multidisciplinary Approaches:
    Recent papers highlight the integration of various specialties in liver care, emphasizing collaborative approaches that include gastroenterology, nutrition, and mental health.
  6. Focus on Non-Alcoholic Fatty Liver Disease (NAFLD):
    Research on NAFLD and its associated metabolic disorders is increasingly prominent, reflecting the rising prevalence of these conditions and their implications for public health.

Declining or Waning

While the journal maintains a robust focus on various aspects of hepatology, certain themes have become less prominent in recent issues, suggesting a shift in research priorities or a saturation of previously explored topics.
  1. Case Studies and Anecdotal Reports:
    There has been a noticeable decline in the publication of individual case studies, indicating a potential shift towards more comprehensive cohort studies and systematic reviews.
  2. Traditional Hepatitis Treatment Protocols:
    Research focusing on older treatment methods for hepatitis, such as interferon therapies, appears to be waning in favor of studies on newer direct-acting antiviral agents.
  3. General Reviews without New Insights:
    The frequency of purely descriptive reviews without significant new findings or insights has decreased, as the journal seeks more innovative and impactful contributions.
  4. Focus on Rare Liver Diseases:
    While rare liver diseases are still relevant, papers specifically addressing these conditions have diminished, possibly indicating a preference for more common and impactful liver conditions.
  5. Pharmacological Studies of Established Drugs:
    The exploration of well-established pharmacological treatments for liver diseases has seen a decline, suggesting a shift towards novel therapies and research methodologies.

Similar Journals

HEPATOLOGY RESEARCH

Exploring the frontiers of Hepatology and infectious diseases.
Publisher: WILEYISSN: 1386-6346Frequency: 12 issues/year

Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Elevating standards in gastrointestinal and liver research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0954-691XFrequency: 12 issues/year

The EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a key platform for disseminating cutting-edge research in the fields of gastroenterology and hepatology since its inception in 1989. With its ISSN 0954-691X and E-ISSN 1473-5687, the journal has established a prominent reputation, as reflected in its 2023 rankings, placing it in Q2 for Gastroenterology and Q3 for Hepatology. It is ranked #75 out of 167 in gastroenterology and #39 out of 82 in hepatology according to Scopus, highlighting its importance in advancing knowledge and clinical practices. While it does not currently offer open access options, the journal remains essential for researchers, healthcare professionals, and students seeking to stay abreast of significant developments and innovations in digestive health. By providing rigorous peer-reviewed articles, the EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY continues to contribute to the understanding and treatment of gastrointestinal and liver diseases, making it a vital resource in the medical community.

Hepatology Forum

Empowering knowledge exchange for liver disease advancements.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

Annals of Hepatology

Elevating knowledge and collaboration in liver research.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.

LIVER INTERNATIONAL

Advancing hepatology through cutting-edge research.
Publisher: WILEYISSN: 1478-3223Frequency: 12 issues/year

LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.

JGH Open

Empowering the Future of Gastrointestinal Medicine
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Translational Gastroenterology and Hepatology

Fostering Global Collaboration in Gastrointestinal Science.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Korean Journal of Gastroenterology

Advancing Knowledge in Gastrointestinal Health
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Egyptian Liver Journal

Exploring breakthroughs in liver disease research.
Publisher: SPRINGEROPENISSN: 2090-6218Frequency: 1 issue/year

The Egyptian Liver Journal, ISSN 2090-6218, is a vital resource for the hepatology community, published by SPRINGEROPEN. Since its establishment in 2012, this journal has served as a platform for disseminating significant findings in liver research, with an emphasis on enhancing understanding and treatment of liver diseases. Recognized with a Q3 ranking in Hepatology for 2023, the Egyptian Liver Journal aims to bridge the gap between research and clinical practice through its commitment to open access, fostering a global exchange of knowledge without barriers since 2019. With a focus on innovative studies, reviews, and clinical guidelines, the journal appeals to a diverse audience of researchers, clinicians, and students dedicated to advancing liver health. Situated in the heart of the United States, this publication addresses the pressing issues within the field and encourages submissions that address the future of liver care and treatment.

Frontline Gastroenterology

Transforming Understanding of Gastrointestinal Diseases
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.